BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 1463866)

  • 21. Alpha 1-antichymotrypsin complexes in human breast cyst fluids.
    Mannello F; Malatesta M; Bocchiotti G; Gazzanelli G
    Cancer Lett; 1994 Jan; 76(2-3):155-9. PubMed ID: 8149344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of progesterone-binding breast cyst protein GCDFP-24 secretion by estrogens and androgens in human breast cancer cells: a new marker of steroid action in breast cancer.
    Simard J; Dauvois S; Haagensen DE; Lévesque C; Mérand Y; Labrie F
    Endocrinology; 1990 Jun; 126(6):3223-31. PubMed ID: 2351114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidermal growth factor content of breast cyst fluids from women with breast cancer or proliferative disease of the breast.
    Torrisi R; Zanardi S; Pensa F; Valenti G; De Franchis V; Nicolo G; Barreca A; Minuto F; Boccardo F
    Breast Cancer Res Treat; 1995 Mar; 33(3):219-24. PubMed ID: 7749149
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apolipoprotein D is the major protein component in cyst fluid from women with human breast gross cystic disease.
    Balbín M; Freije JM; Fueyo A; Sánchez LM; López-Otín C
    Biochem J; 1990 Nov; 271(3):803-7. PubMed ID: 2244881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conjugated bile acids in breast cyst fluids: relationship to cation-related cyst subpopulations.
    Mannello F; Sebastiani M; Amati S; Gazzanelli G
    Cancer Lett; 1997 Oct; 119(1):21-6. PubMed ID: 18372517
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ultrastructural characterization and biochemical profile of human gross cystic breast disease.
    Malatesta M; Mannello F; Sebastiani M; Cardinali A; Marcheggiani F; Renò F; Gazzanelli G
    Breast Cancer Res Treat; 1998 Apr; 48(3):211-9. PubMed ID: 9598868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Growth inhibitory substances in human breast cyst fluid.
    Lai LC; Chan CT; Cornell C; Lennard TW
    Anticancer Res; 1993; 13(1):225-7. PubMed ID: 8476217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Review of GCDFP-15. An apocrine marker protein.
    Haagensen DE; Dilley WG; Mazoujian G; Wells SA
    Ann N Y Acad Sci; 1990; 586():161-73. PubMed ID: 2192632
    [No Abstract]   [Full Text] [Related]  

  • 29. Association of cyst type with risk factors for breast cancer and relapse rate in women with gross cystic disease of the breast.
    Naldoni C; Costantini M; Dogliotti L; Bruzzi P; Bucchi L; Buzzi G; Torta M; Angeli A
    Cancer Res; 1992 Apr; 52(7):1791-5. PubMed ID: 1551110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostate-specific antigen found in type I breast cyst fluids is a secretory product of the apocrine cells lining breast gross cysts.
    Malatesta M; Mannello F; Sebastiani M; Bianchi G; Gazzanelli G
    Breast Cancer Res Treat; 1999 Sep; 57(2):157-63. PubMed ID: 10598042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Products of exocrine secretion of the breast and breast cancer].
    Franchimont P; Collette J; Zangerle PF; Hendrick JC
    Ann Med Interne (Paris); 1984; 135(5):385-9. PubMed ID: 6486618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interactions between estrogens, androgens, progestins, and glucocorticoids in ZR-75-1 human breast cancer cells.
    Labrie F; Poulin R; Simard J; Zhao HF; Labrie C; Dauvois S; Dumont M; Hatton AC; Poirier D; Mérand Y
    Ann N Y Acad Sci; 1990; 595():130-48. PubMed ID: 2142871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enterolactone in breast cyst fluid: correlation with EGF and breast cancer risk.
    Boccardo F; Lunardi GL; Petti AR; Rubagotti A
    Breast Cancer Res Treat; 2003 May; 79(1):17-23. PubMed ID: 12779078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of amniotic fluid, maternal plasma, and cord blood for a human breast gross cystic disease fluid protein.
    Haagensen DE; Gall SA; Brazy JE; Giannola J; Wells SA
    Am J Obstet Gynecol; 1980 Sep; 138(1):25-32. PubMed ID: 7416203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Accumulation of active androgens in breast cyst fluids.
    Secreto G; Recchione C; Ballerini P; Callegari L; Cavalleri A; Attili A; Fariselli G; Moglia D; Del Prato I
    Eur J Cancer; 1991; 27(1):44-7. PubMed ID: 1826440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantification and molecular analysis of cathepsin D in breast cyst fluids.
    Sánchez LM; Vizoso F; Allende MT; Ruibal A; López-Otín C
    Eur J Cancer; 1992; 28A(4-5):828-32. PubMed ID: 1524902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human gross cyst breast disease and cystic fluid: bio-molecular, morphological, and clinical studies.
    Mannello F; Tonti GA; Papa S
    Breast Cancer Res Treat; 2006 May; 97(2):115-29. PubMed ID: 16331347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [An immunohistochemical study of normal sweat glands using an antibody to the breast cyst fluid protein (GCDFP-15)].
    Komatsu T; Tajima S; Nishikawa T
    Nihon Hifuka Gakkai Zasshi; 1989 Aug; 99(9):985-9. PubMed ID: 2689726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidermal growth factor levels in human breast cyst fluid.
    Battaglia F; Rossi S; Scambia G; Lanzone A; Benedetti-Panici P; Ferrandina G; Lombardi CP; Bellantone R; Crucitti F; Mancuso S
    Anticancer Res; 1989; 9(6):1661-3. PubMed ID: 2627118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipids status in human breast cyst fluids.
    Mannello F; Bocchiotti GD; Morano FP; Fratepietro LM; Gazzanelli G
    Cancer Lett; 1996 Jan; 98(2):137-43. PubMed ID: 8556700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.